43731 Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years

Journal of The American Academy of Dermatology(2023)

Cited 0|Views8
No score
Abstract
Background: Intense itch is described as the most burdensome symptom of atopic dermatitis (AD), with negative impact on quality of life, sleep, and mental health.
More
Translated text
Key words
dupilumab reduces itch,atopic dermatitis,moderate-to-severe
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined